SI2555763T1 - Sestavki virusni inhibitor za terapevtsko uporabo in vivo, ki obsega kombinacijo (-)-karvon, (+)-karvon, geraniol in nadalje komponento eteričnega olja - Google Patents

Sestavki virusni inhibitor za terapevtsko uporabo in vivo, ki obsega kombinacijo (-)-karvon, (+)-karvon, geraniol in nadalje komponento eteričnega olja

Info

Publication number
SI2555763T1
SI2555763T1 SI201130216T SI201130216T SI2555763T1 SI 2555763 T1 SI2555763 T1 SI 2555763T1 SI 201130216 T SI201130216 T SI 201130216T SI 201130216 T SI201130216 T SI 201130216T SI 2555763 T1 SI2555763 T1 SI 2555763T1
Authority
SI
Slovenia
Prior art keywords
carvone
geraniol
combination
essential oil
therapeutic use
Prior art date
Application number
SI201130216T
Other languages
English (en)
Inventor
Christine Coppens
Original Assignee
Cesa Alliance S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42102951&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI2555763(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cesa Alliance S.A. filed Critical Cesa Alliance S.A.
Publication of SI2555763T1 publication Critical patent/SI2555763T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SI201130216T 2010-03-26 2011-03-28 Sestavki virusni inhibitor za terapevtsko uporabo in vivo, ki obsega kombinacijo (-)-karvon, (+)-karvon, geraniol in nadalje komponento eteričnega olja SI2555763T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10157930A EP2368547B1 (en) 2010-03-26 2010-03-26 Antiviral compositions comprising geraniol and carvone
PCT/EP2011/054758 WO2011117424A1 (en) 2010-03-26 2011-03-28 Viral inhibitor compositions for in vivo therapeutic use comprising a combination of (-) -carvone, geraniol and a further essential oil component
EP11710232.7A EP2555763B1 (en) 2010-03-26 2011-03-28 Viral inhibitor compositions for in vivo therapeutic use comprising a combination of (-)-carvone, (+)-carvone, geraniol and a further essential oil component

Publications (1)

Publication Number Publication Date
SI2555763T1 true SI2555763T1 (sl) 2014-08-29

Family

ID=42102951

Family Applications (2)

Application Number Title Priority Date Filing Date
SI201030084T SI2368547T1 (sl) 2010-03-26 2010-03-26 Protivirusni pripravki, ki vsebujejo geraniol in karvon
SI201130216T SI2555763T1 (sl) 2010-03-26 2011-03-28 Sestavki virusni inhibitor za terapevtsko uporabo in vivo, ki obsega kombinacijo (-)-karvon, (+)-karvon, geraniol in nadalje komponento eteričnega olja

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SI201030084T SI2368547T1 (sl) 2010-03-26 2010-03-26 Protivirusni pripravki, ki vsebujejo geraniol in karvon

Country Status (35)

Country Link
US (2) US8980945B2 (sl)
EP (2) EP2368547B1 (sl)
JP (1) JP5342085B2 (sl)
KR (1) KR101340260B1 (sl)
CN (1) CN102946876B (sl)
AU (1) AU2011231511B2 (sl)
BR (1) BR112012024260B1 (sl)
CA (1) CA2790087C (sl)
CL (1) CL2012002606A1 (sl)
CO (1) CO6602166A2 (sl)
CY (3) CY1113449T1 (sl)
DK (2) DK2368547T3 (sl)
EA (1) EA025278B9 (sl)
ES (2) ES2392938T3 (sl)
HK (1) HK1176019A1 (sl)
HR (2) HRP20120964T1 (sl)
HU (1) HUE026121T2 (sl)
IL (1) IL222048A (sl)
LU (1) LU91805B1 (sl)
MA (1) MA34074B1 (sl)
ME (1) ME02035B (sl)
MX (1) MX346412B (sl)
MY (2) MY153104A (sl)
NZ (1) NZ602602A (sl)
PE (2) PE20130065A1 (sl)
PL (2) PL2368547T3 (sl)
PT (2) PT2368547E (sl)
RS (2) RS52544B (sl)
SG (1) SG184039A1 (sl)
SI (2) SI2368547T1 (sl)
SM (2) SMT201200062B (sl)
TN (2) TN2012000444A1 (sl)
UA (1) UA102497C2 (sl)
WO (1) WO2011117424A1 (sl)
ZA (2) ZA201208116B (sl)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN2014MN00808A (sl) 2011-11-03 2015-09-04 Unilever Plc
WO2013083592A1 (en) 2011-12-06 2013-06-13 Unilever N.V. Antimicrobial composition
EP2787825B2 (en) 2011-12-06 2021-11-03 Unilever Global IP Limited Antimicrobial composition
CN104023539B (zh) 2011-12-06 2021-08-13 联合利华知识产权控股有限公司 抗微生物组合物
WO2014001092A1 (en) 2012-06-27 2014-01-03 Unilever N.V. Antimicrobial composition
RU2533254C2 (ru) * 2012-12-29 2014-11-20 Федеральное государственное бюджетное учреждение научно-исследовательский институт детских инфекций Федерального медико-биологического агентства Способ лечения неврологических осложнений при ветряной оспе у детей
TWI463979B (zh) * 2013-04-12 2014-12-11 Nat Defense Medical Ct 檸檬醛用於製備治療局部腎絲球硬化症之藥物的用途
KR20150145314A (ko) 2014-06-18 2015-12-30 원광대학교산학협력단 카르본을 유효성분으로 포함하는 항균 조성물
CN106727628A (zh) * 2016-12-17 2017-05-31 郑州郑先医药科技有限公司 一种治疗慢性腹泻的西药组合物
KR101970281B1 (ko) * 2017-07-28 2019-04-18 고려대학교 산학협력단 리나릴 아세테이트를 포함하는 올메사탄으로 유발된 장운동과다증의 예방 또는 치료용 조성물
CN107648488A (zh) * 2017-09-29 2018-02-02 陈晓阳 一种用于治疗慢性咽炎的丸剂
KR102118181B1 (ko) * 2018-06-12 2020-06-02 광주여자대학교 산학협력단 식물성 정유를 유효성분으로 포함하는 a형 인플루엔자 바이러스에 대한 항바이러스 조성물
RU2707950C1 (ru) * 2018-11-28 2019-12-02 Общество с ограниченной ответственностью "ЭРБИ" Средство для обработки среды пребывания птицы на основе липосом с фитокомпозицией с иммунотропным действием и избирательным антисептическим эффектом и способ его применения
US20200179299A1 (en) * 2018-12-07 2020-06-11 Global Biolife Inc. Composition and method of controlling infectious diseases with functional fragrances
CN110496117B (zh) * 2019-09-30 2022-09-06 中国科学院微生物研究所 一种小分子化合物在抗非洲猪瘟病毒感染中的新应用
CN111012769B (zh) * 2019-12-05 2021-02-12 青海大学 一种用于治疗包虫病的药物组合物、药物制剂及乳剂制备方法
SG10201914042SA (en) * 2019-12-31 2021-07-29 Xj Bio Engineering Int Pte Ltd Feed additive for preventing african swine fever disease or replacing antibiotic growth promoters and methods of making and using the same
WO2021224947A1 (en) * 2020-05-02 2021-11-11 Norouzi Mehdi Formulation of acute respiratory disease control formulation
CN114702376A (zh) * 2020-12-14 2022-07-05 中南民族大学 柏木醇衍生物、其制备方法及其应用
CA3102947A1 (en) * 2020-12-18 2022-06-18 Skymount Medical Us Inc. Nutraceuticals useful in the treatment of coronavirus diseases
CN115141681B (zh) * 2021-03-30 2024-06-21 湖南诺泽生物科技有限公司 挥发油、其制备方法及用途
JP7133820B1 (ja) 2021-06-09 2022-09-09 塩野香料株式会社 コロナウイルス感染症予防用香料組成物及び結合阻害剤
CN113994963B (zh) * 2021-09-26 2023-04-28 中国农业科学院烟草研究所(中国烟草总公司青州烟草研究所) 一种含有乙酸二氢香芹酯的抑芽剂及其用途
TWI800937B (zh) * 2021-10-01 2023-05-01 奇美醫療財團法人奇美醫院 用於治療登革熱病毒感染之方法
WO2024097158A1 (en) * 2022-11-01 2024-05-10 Ramirez Christina M Viral prophylaxis treatment methods and pre-exposure prophylaxis kits
CN117338758B (zh) * 2023-12-06 2024-03-12 北京远大九和药业有限公司 一种药物组合物及其用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5667M (sl) 1966-03-10 1968-01-02
LU78955A1 (de) 1978-01-27 1979-09-06 Chimicasa Gmbh Verfahren zur inaktivierung von viren
US4902678A (en) * 1982-02-12 1990-02-20 Syntex (U.S.A.) Inc. Anti-viral compositions
US5856364A (en) * 1991-03-01 1999-01-05 Warner Lambert Company Therapeutic antiviral-wound healing compositions and methods for preparing and using same
US5716928A (en) * 1995-06-07 1998-02-10 Avmax, Inc. Use of essential oils to increase bioavailability of oral pharmaceutical compounds
AU2002217316A1 (en) * 2001-01-03 2002-07-30 Medpharma Plc Use of terpenes for the treatment of digestive tract infections
US20040071757A1 (en) * 2001-11-20 2004-04-15 David Rolf Inhalation antiviral patch
KR20140103191A (ko) * 2005-11-30 2014-08-25 에덴 리서치 피엘씨 티몰, 유게놀, 게라니올, 시트랄, 및 ｌ―카르본에서 선택된 테르펜 또는 테르펜 혼합물을 포함하는 조성물 및 방법
EP2125171A4 (en) * 2007-01-10 2012-05-16 Univ Michigan ULTRAFILTRATION MEMBRANE, DEVICE, BIOARTIFICIAL ORGAN AND CORRESPONDING METHOD
KR100796312B1 (ko) * 2007-05-23 2008-01-21 주식회사 바이오미스트테크놀로지 게라니얼，네랄 및 유게놀을 유효성분으로 함유하는 동물용소독제 조성물
KR100941595B1 (ko) 2008-06-05 2010-02-11 주식회사 알앤엘바이오 바이러스 억제제로서 유용한 트리테르페노이드계 화합물
KR100950428B1 (ko) 2008-06-05 2010-04-02 주식회사 알앤엘바이오 바이러스 억제제로서 유용한 디아릴헵타노이드계 화합물

Also Published As

Publication number Publication date
EP2368547A1 (en) 2011-09-28
US8980945B2 (en) 2015-03-17
AU2011231511A1 (en) 2012-10-18
BR112012024260A2 (pt) 2016-07-12
CY1115375T1 (el) 2017-01-04
MX346412B (es) 2017-03-17
CY1119841T1 (el) 2018-06-27
ES2392938T3 (es) 2012-12-17
MA34074B1 (fr) 2013-03-05
EP2555763A1 (en) 2013-02-13
SG184039A1 (en) 2012-10-30
EA025278B9 (ru) 2017-03-31
HK1176019A1 (en) 2013-07-19
UA102497C2 (ru) 2013-07-10
CO6602166A2 (es) 2013-01-18
ZA201208116B (en) 2014-04-30
EA201270749A1 (ru) 2013-03-29
CA2790087C (en) 2013-07-30
CY1113449T1 (el) 2016-06-22
PL2555763T3 (pl) 2014-09-30
SMT201400104B (it) 2014-09-08
CL2012002606A1 (es) 2013-10-18
EA025278B1 (ru) 2016-12-30
JP5342085B2 (ja) 2013-11-13
HUE026121T2 (en) 2016-05-30
KR101340260B1 (ko) 2013-12-10
MY158757A (en) 2016-11-15
PT2555763E (pt) 2014-08-04
ZA201306926B (en) 2014-04-30
HRP20140706T1 (hr) 2014-09-12
PE20130065A1 (es) 2013-03-08
PE20141008A1 (es) 2014-09-20
BR112012024260B1 (pt) 2019-12-31
TN2012000444A1 (en) 2014-01-30
MX2012010949A (es) 2013-01-29
US8883859B1 (en) 2014-11-11
SI2368547T1 (sl) 2013-01-31
CN102946876A (zh) 2013-02-27
SMT201200062B (it) 2013-03-08
EP2368547B1 (en) 2012-09-12
KR20120128716A (ko) 2012-11-27
WO2011117424A1 (en) 2011-09-29
PT2368547E (pt) 2012-11-20
LU91805B1 (fr) 2011-09-26
US20130225676A1 (en) 2013-08-29
JP2013523622A (ja) 2013-06-17
IL222048A (en) 2014-09-30
ME02035B (me) 2013-04-30
DK2368547T3 (da) 2013-01-02
CN102946876B (zh) 2016-04-06
CA2790087A1 (en) 2011-09-29
DK2555763T3 (da) 2014-08-04
ES2486765T3 (es) 2014-08-19
EP2555763B1 (en) 2014-04-30
HRP20120964T1 (en) 2012-12-31
RS53435B (en) 2014-12-31
AU2011231511B2 (en) 2014-03-20
NZ602602A (en) 2012-12-21
MY153104A (en) 2014-12-31
RS52544B (en) 2013-04-30
TN2013000366A1 (en) 2015-01-20
PL2368547T3 (pl) 2013-02-28

Similar Documents

Publication Publication Date Title
PT2555763E (pt) Composições inibidoras virais para utilização terapêutica in vivo que compreendem uma combinação de (-)-carvona, (+)- carnona, geraniol e um componente de óleo essencial adicional
IL250824B (en) Certain amino-pyrimidines, their assemblies, and methods of using them
HK1194071A1 (en) Certain triazolopyrazines, compositions thereof and methods of use therefor
EP2536756A4 (en) HSA-RELATED COMPOSITIONS AND USE PROCESSES
EP2584897A4 (en) COMPOSITIONS CONTAINING RESVERATROL AND METHODS OF USE
EP2646468A4 (en) ANTI-NGF COMPOSITIONS AND THEIR USE
EP2640792A4 (en) ADHESIVE COMPOSITIONS AND USES THEREOF
ZA201008232B (en) Lipid-containing compositions and methods of use thereof
IL225227A0 (en) Preparations including fulvestrant and methods of use
EP2596112A4 (en) ACETYCYSTEIN COMPOSITIONS AND USE METHOD THEREFOR
EP2582664A4 (en) PHENYL THIOACETATE COMPOUNDS AND COMPOSITIONS AND METHOD FOR THEIR USE
EP2575444A4 (en) DILUTABLE BIOZIDE COMPOSITIONS AND USE METHOD THEREFOR
EP2515647A4 (en) PHEROMONIC COMPOSITIONS AND METHODS OF USE
EP2231665A4 (en) NEW COMPOSITIONS AND METHODS OF USE
EP2588117A4 (en) STABLE ANTISEPTIC COMPOSITIONS AND METHODS
EP2506709A4 (en) AMANTADIN COMPOSITIONS AND METHODS OF USE THEREOF
EP2590971A4 (en) COMPOUNDS USEFUL AS ANTIVIRAL AGENTS, COMPOSITIONS, AND METHODS OF USE
EP2622029A4 (en) PRINTING COLORING COMPOSITIONS AND METHOD FOR THEIR USE
ZA201302952B (en) Fungicidal compositions and methods of use
HK1166953A1 (en) Compositions and methods of use
ZA201200260B (en) Polyphenylsulphone-polytetrafluroethylene compositions and use thereof
EP2588118A4 (en) IMMUNOGENICALLY CONSTRAINED COMPOSITIONS AND THEIR APPLICATIONS
EP2649096A4 (en) HEMOGLOBIN COMPOSITIONS AND METHODS OF USE
EP2637501A4 (en) FUNGICIDES AND METHODS OF USE THEREOF
GB201005826D0 (en) New compositions and their use